In a study of advanced NSCLC patients, multivariate analysis identified visceral metastases, tumor burden, EGFR mutations, and TP53 mutations as independent predictors of increased ctDNA shedding [33]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.